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Introduction
Endochondral ossifi  cation is the process by which most long 
bones of the body are formed (Provot and Schipani, 2005). Dur-
ing endochondral ossifi  cation, mesenchymal cells fi  rst aggregate 
to form condensations (Hall and Miyake, 2000). The cells in the 
center of these condensations differentiate into chondrocytes, 
forming the cartilaginous template, whereas the undifferenti-
ated cells at the periphery form the surrounding perichondrium 
(Horton, 1993). After formation of the cartilage template, the 
innermost chondrocytes differentiate into hypertrophic chon-
drocytes and the cells of the inner layer of the perichondrium 
differentiate into osteoblasts (Komori et al., 1997; Otto et al., 
1997), forming a bone collar around the cartilaginous core 
(Caplan and Pechak, 1987). The hypertrophic cells secrete a 
distinct ECM that gradually becomes calcifi  ed (Poole, 1991). 
This specialized matrix allows for vascular invasion from the 
bone collar and the entry of osteoclasts and osteoblasts that de-
grade the mineralized cartilage matrix and deposit bone (Ortega 
et al., 2003). Apoptosis of hypertrophic cells and the deposition 
of a matrix rich in type I collagen (Col I) results in two opposing 
growth plates that allow for longitudinal bone growth in both 
directions. This process is in contrast to the craniofacial skeleton 
bones that are formed by intramembranous ossifi  cation, where 
mesenchymal cells directly differentiate into bone without an 
intermediate cartilage template.
In this paper, we have identifi  ed site-1 protease (S1P) as a 
new player involved in regulating endochondral ossifi  cation. 
S1P (also known as membrane-bound transcription factor prote-
ase, site 1) is a proprotein convertase and a key member of the 
regulated intramembrane proteolysis pathway involved in the 
unfolded protein response and cholesterol homeostasis (Brown 
et al., 2000). A role for S1P in cartilage development was shown 
through the study of the zebrafi  sh gonzo mutant (Schlombs et al., 
2003), which has both lipid and skeletal abnormalities. S1P plays 
a critical role in the processing of the sterol regulatory element 
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ite-1 protease (S1P) has an essential function in the 
conversion of latent, membrane-bound transcrip-
tion factors to their free, active form. In mammals, 
abundant expression of S1P in chondrocytes suggests an 
involvement in chondrocyte function. To determine the re-
quirement of S1P in cartilage and bone development, we 
have created cartilage-speciﬁ  c S1P knockout mice (S1P
cko). 
S1P
cko mice exhibit chondrodysplasia and a complete 
lack of endochondral ossiﬁ  cation even though Runx2 expres-
sion, Indian hedgehog signaling, and osteoblastogenesis 
is intact. However, there is a substantial increase in chon-
drocyte apoptosis in the cartilage of S1P
cko mice. Extraction 
of type II collagen is substantially lower from S1P
cko carti-
lage. In S1P
cko mice, the collagen network is disorganized 
and collagen becomes entrapped in chondrocytes. Ultra-
structural analysis reveals that the endoplasmic reticulum 
(ER) in S1P
cko chondrocytes is engorged and fragmented 
in a manner characteristic of severe ER stress. These data 
suggest that S1P activity is necessary for a specialized ER 
stress response required by chondrocytes for the genesis 
of normal cartilage and thus endochondral ossiﬁ  cation.
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binding proteins (SREBP-1a, -1c, and -2; Eberle et al., 2004). 
SREBPs are membrane-bound transcription factors in the ER 
and regulate cholesterol and fatty acid biosynthesis and uptake. 
When cholesterol levels are high, SREBP is retained in the ER 
membrane as a complex with the sterol-sensing protein SREBP 
cleavage–activating protein (SCAP) and the retention protein 
INSIG (insulin induced gene). When cholesterol levels drop, the 
SREBP–SCAP complex dissociates from INSIG and trans-
locates to the Golgi bodies, where SREBP is sequentially cleaved 
by S1P and S2P to release the amino-terminal domain of SREBP 
containing the basic helix-loop-helix leucine zipper region. The 
basic helix-loop-helix leucine zipper region translocates to the 
nucleus to bind to cis-acting sterol responsive elements. In a 
similar fashion, S1P is also involved in the activation of other ER 
membrane-bound proteins such as activating transcription factor 6 
(ATF6; Haze et al., 1999; Ye et al., 2000), old astrocyte specifi  -
cally induced substance (OASIS; Murakami et al., 2006), and 
cAMP-responsive element binding protein H (CREBH; Zhang 
et al., 2006), which are transcription factors for the unfolded pro-
tein response target genes.
To elucidate the role of S1P in all aspects of skeletal 
development, we created cartilage-specifi  c S1P knockout mice 
(S1P
cko) using a Col2a1 promoter. S1P
cko mice die shortly after 
birth and exhibit severe chondrodysplasia. The cartilage matrix 
is abnormal in S1P
cko mice with defects in Col II protein secre-
tion and assimilation into the matrix, and endochondral bone 
formation is completely absent. This is the fi  rst example of a 
defect in a regulated intramembrane proteolysis enzyme that 
affects cartilage development and endochondral ossifi  cation in 
mice. Deletions of various matrix metalloproteinases (MMPs), 
such as MMP13 or MMP9 (Inada et al., 2004; Stickens et al., 
2004), thought to be important in bone morphogenesis did not 
abolish endochondral ossifi  cation. Thus, S1P is a unique en-
zyme that plays an integral role in skeletal development.
Results
S1P
cko mice exhibit severe chondrodysplasia
To produce mice lacking S1P in the cartilage, the Col2-Cre re-
combinase was used to delete exon 2 of S1P. S1P
f/+;Col2-Cre 
mice were bred with S1P
f/f mice to generate conditional knock-
out S1P
f/f;Col2-Cre (S1P
cko) mice. S1P
cko mice exhibit severe 
chondrodysplasia (Fig. 1 A) with deformed limbs, a protruding 
tongue (Fig. 1 B), and a distended belly and die during or shortly 
after birth. All structural elements are present in S1P
cko mice but 
are considerably smaller than in wild-type (WT) mice (Fig. 1 C). 
Fig. 1 D shows a detailed analysis of the skeletal elements. The 
smaller skull in S1P
cko mice, caused by a shortened chondo-
cranial base coupled with foreshortened mandibles and upper 
jaw bones, appears to be responsible for the protrusion of the 
tongue. The skull bones show increased sensitivity to potassium 
hydroxide (used for clearing the tissue during skeletal staining) 
Figure 1.  Severe chondrodysplasia in S1P
cko mice. (A) Newborn S1P
cko mice (right) exhibit severe chondrodysplasia as compared with WT mice (left). 
(B) S1P
cko mice have a smaller skull and foreshortened mandibles, which results in the protrusion of the tongue. (C) Whole animal skeletal preparation of WT 
(left) and S1P
cko (right) newborns. (D) The skeletal patterning in S1P
cko mice is similar to WT mice, but all the skeletal elements are smaller. The arrow points 
to the furrow that is formed in S1P
cko skull (absent in WT) during skeletal staining, which suggests a lack of structural integrity of the skull bones.SITE-1 PROTEASE AND CARTILAGE AND BONE • PATRA ET AL. 689
that resulted in the dissolution of the bones in the back of the 
skull (Fig. 1 D, arrow), which remain intact in the WT. The chest 
cavity is small and presses the internal organs into the abdominal 
cavity, giving the belly a distended appearance. The smaller 
chest cavity probably causes acute neonatal respiratory distress 
and subsequent lethality. The skewed orientation of the limbs, 
particularly the hind limbs, suggests anomalous articular joint 
development. Heterozygotes (S1P
f/+;Col2-Cre) appear normal and 
do not show any phenotype (unpublished data).
To confi  rm that the phenotype in S1P
cko mice is caused by 
a lack of S1P, we analyzed the expression of the S1P gene in 
chondrocytes in different developmental stages by in situ hybrid-
ization (Fig. 2). S1P is abundantly expressed in the chondro-
cytes in the developing WT forelimb at all stages (Fig. 2, A–D). 
The heterozygotes show drastic reduction in S1P expression in 
chondrocytes but show normal bone development, with expression 
in bone and surrounding tissues intact (Fig. 2, E and F). As 
expected, the homozygous knockout (S1P
cko) does not show 
any S1P expression in skeletal tissues (Fig. 2 H). These data 
suggest that the mutant phenotype could be directly attributed 
to the effi  cient knockout of both copies of S1P in the cartilage 
in S1P
cko mice.
Lack of organized hypertrophy and 
endochondral ossiﬁ  cation in S1P
cko mice
As S1P
cko mice die during or shortly after birth, we conducted a 
histological analysis of various skeletal elements at different em-
bryonic stages. S1P
cko mice lack an organized hypertrophic zone 
and endochondral ossifi  cation, as shown for the humerus at dif-
ferent stages (Fig. 3). At embryonic day (E) 13.5, no major dif-
ferences are observed in the morphology of the humerus between 
S1P
cko and WT mice. At E13.75 (7 h after E13.5), the WT hu-
merus increased in size and the chondrocytes in the center initi-
ated hypertrophy. S1P
cko mice, however, showed only a slight 
increase in the size of the humerus at E13.75. The transition from 
proliferating to hypertrophic cells appears to be initiated but does 
not progress to hypertrophy, though a change in morphology of 
the cells at the center of the humerus is noticeable. At E14.5, the 
humerus in WT mice has considerably increased in size and hy-
pertrophy is completely established. In S1P
cko mice, however, the 
transition from proliferating to hypertrophic cells is still incom-
plete at E14.5. At E15.5, endochondral bone is observed in WT 
mice with the establishment of a growth plate. However, at E15.5, 
S1P
cko mice still do not exhibit an organized hypertrophic zone. 
Notably, there is no endochondral ossifi  cation or growth plate, 
and, consequently, the humerus is small compared with the WT. 
In the absence of endochondral bone, however, there is an exuber-
ant growth of the bone collar (Fig. 3, arrow).
At E18.5, it is clear that S1P
cko mice suffer from a lack of 
endochondral bone formation and a structured growth plate, 
rather than a delay. At this stage, the exuberant bone collar often 
impinges into the diaphysis and bisects it. A lack of endochon-
dral ossifi  cation is also observed in the hind limbs, sternum, ribs, 
and spine (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200708092/DC1). Although a hypertrophic zone is not 
seen in S1P
cko mice, they have the ability to make hypertrophic 
cells, which is more distinguishable in later developmental 
stages (Fig. S2). In summary, a lack of organized endochondral 
ossifi  cation is observed in all skeletal elements in S1P
cko mice 
because of the disruption of S1P activity.
Indian hedgehog (Ihh) signaling is intact 
in S1P
cko mice
Because of a lack of endochondral ossifi  cation in S1P
cko mice, 
we examined Ihh signaling, which is known to be an essential 
regulator of chondrocyte proliferation and hypertrophic differ-
entiation. Ihh’s function is thought to be dependent on lipophilic 
modifi  cations critical for the spatially restricted localization of 
Ihh signaling (Gritli-Linde et al., 2001). In the growth plate, Ihh 
Figure 2.  In situ hybridization analysis of S1P gene. Expression of S1P is 
ubiquitous, although expression is stronger in the skeletal elements with use 
of the full-length S1P in situ probe (A–E). (A) S1P is expressed abundantly 
in immature chondrocytes in the humerus (hu), radius (r), and ulna (u) in the 
forelimb of the WT at E13.5. (B) At E14.5, expression of S1P decreases 
considerably in the hypertrophic (h) chondrocytes in the humerus of the WT. 
(C) At E15.5, expression of S1P is seen in the newly deposited bone (b) in 
the WT. (D) At E18.5, expression of S1P is seen throughout the humerus, 
including the hypertrophic cells (bracket) and bone trabeculae in the WT. 
(E) Expression of S1P is drastically reduced in the chondrocytes of the het-
erozygotes (S1P
f/+;Col2-Cre) but is normal in bone and surrounding tissue 
(E18.5) using the full-length probe or against exon 2 of S1P (F). Brackets in-
dicate hypertrophic cells. In situ analysis for S1P using the exon 2 probe in 
E13.5 WT (G) and S1P
cko (H) forelimb. In S1P
cko mice, expression signaling 
from exon 2 is absent in the skeletal tissues. s, scapula. Bar, 500 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  690
is distributed in a gradient that is necessary for coordinated 
chondrocyte proliferation and differentiation (Koziel et al., 
2004). As cholesterol and fatty acid synthesis is likely to be af-
fected in chondrocytes because of the absence of S1P, it could 
lead to defects in Ihh signaling. A defect in Ihh signaling is as-
sociated with a decrease in chondrocyte proliferation (St-Jacques 
et al., 1999). Thus, to analyze the nature of Ihh signaling in our 
model, we labeled proliferating chondrocytes with BrdU at 
E14.5 (Fig. 4, A and B). Notably, at E14.5, analysis of the pro-
liferating BrdU-labeled cells revealed that both WT and S1P
cko 
mice exhibit nearly identical rates of proliferation (Fig. 4 C). 
Moreover, WT and S1P
cko proliferating chondrocytes displayed 
the ability to exit the cell cycle, as seen by a lack of BrdU incor-
poration as they progressed toward hypertrophic differentiation 
(Fig. 4, A and B).
The Ihh null mutant is also characterized by a lack of expres-
sion of its receptor and transcriptional target Patched-1 (Ptc-1) 
and parathyroid hormone-related peptide (PTHrP; St-Jacques 
et al., 1999). PTHrP and its receptor PTHrP-R play important 
roles in the control of hypertrophic differentiation (Lanske et al., 
1996; Schipani et al., 1997). Therefore, we analyzed the ex-
pression of Ptc-1 and PTHrP in S1P
cko mice by in situ hybridiza-
tion. Expression of both Ptc-1 (Fig. 4 E) and PTHrP (Fig. 4 G) 
is seen in S1P
cko mice, though the expression of Ptc-1 is not 
completely similar to WT mice and PTHrP appears slightly re-
duced. Ihh is also required to establish the bone collar by regu-
lating the differentiation of the perichondrial mesenchymal cells 
into osteoblast progenitors (St-Jacques et al., 1999). Con-
sequently, Ihh null mutants do not form a bone collar. Therefore, 
we studied bone collar formation at E13.5 by analyzing the ex-
pression of bone sialoprotein (BSP), a major structural protein 
of the bone matrix specifi  cally expressed by maturing osteo-
blasts. Notably, both WT and S1P
cko mice displayed a timely ex-
pression of BSP in the developing bone collar at E13.5 (Fig. 4, 
H and I). Collectively with Ptc-1 and PTHrP expression, these 
data suggest that Ihh signaling is intact in S1P
cko mice.
Hypertrophic chondrocyte differentiation 
is incomplete in S1P
cko mice
Hypertrophic differentiation begins with the proliferating chon-
drocytes exiting the cell cycle and beginning to express Ihh and 
Runx2 to form the prehypertrophic cells, which exhibit a de-
creased expression of Col2. The fully differentiated hypertrophic 
chondrocytes are large, no longer express Col2, and are charac-
terized by the expression of Col10 and VEGF. In S1P
cko mice, 
hypertrophic differentiation is initiated as chondrocytes exit the 
cell cycle and no longer incorporate BrdU (Fig. 4 B). However, 
under higher magnifi  cation, this region in E14.5 S1P
cko mice 
does not show the same morphology as in the WT (Fig. 5). In the 
WT humerus (Fig. 5 A), there is a clear defi  nition of the hyper-
trophic zone. Above the hypertrophic zone, proliferating chon-
drocytes are seen organized in groups of columnar chondrocytes. 
Between these groups, there is an abundant matrix that stains a 
deep red. In S1P
cko mice (Fig. 5 B), however, columnar organiza-
tion of the cells is absent. Chondrocytes are present in a random 
confi  guration and are more densely packed. Although a few en-
larged cells are present, a distinct hypertrophic zone is absent.
To analyze hypertrophic differentiation in S1P
cko mice, we 
performed a series of in situ hybridizations on E14.5 humerus 
serial sections. First, we analyzed the expression of Runx2. Runx2 
is a powerful positive regulator of chondrocyte maturation into 
hypertrophy, and Runx2 null mice exhibit an absence of both 
endochondral and intramembranous ossifi  cation because of an 
Figure 3.  Lack of organized hypertrophy and endochondral bone forma-
tion in S1P
cko mice. WT and S1P
cko forelimb sections were stained with Saf-
ranin O, Fast green, and hematoxylin at various time points. The humerus 
is shown in all panels. Hypertrophic chondrocytes are visible in WT mice 
as early as E13.75 (7 h after E13.5). These hypertrophic cells are struc-
tured into a distinct hypertrophic zone that is missing in S1P
cko mice. Endo-
chondral bone is evident in WT but absent in S1P
cko mice at E15.5; in the 
absence of endochondral bone, an exuberant bone collar is formed (arrow). 
At E18.5, the exuberant bone collar often impinges into the diaphysis and 
bisects the cartilage. Bar, 200 μm. (insets) High magniﬁ  cation  pictures 
showing the morphology of the chondrocytes near the center of the limb at 
E13.5; the morphology of hypertrophic cells at E13.75; the junction of the 
proliferating and hypertrophic cells at E14.5; the junction of the bone and 
hypertrophic cells for WT; and the center of the limb for the mutant at 
E15.5. Bar, 50 μm.SITE-1 PROTEASE AND CARTILAGE AND BONE • PATRA ET AL. 691
arrest in osteoblastogenesis (Ducy et al., 1997; Komori et al., 1997). 
By in situ analysis, S1P
cko mice showed an expression pattern 
for Runx2 that is similar to the WT in that expression is seen in 
the perichondrium and presumptive prehypertrophic and hyper-
trophic cells (Fig. 5, C and D). To better defi  ne the prehyper-
trophic and hypertrophic regions, we analyzed the expression of 
Ihh and PTHrP-R in prehypertrophic cells and Col10, which is 
expressed only by hypertrophic cells. In WT mice, the Ihh- 
(Fig. 5 E) and PTHrP-R–expressing (Fig. 5 G) prehypertrophic 
cells and the Col10-expressing (Fig. 5 I) hypertrophic cells form 
well-defi  ned regions, with the prehypertrophic cells always ly-
ing proximal (from the humerus head) to the hypertrophic cells. 
Figure 4.  Intact Ihh signaling in S1P
cko mice. (A and B) IHC with anti-BrdU antibodies, showing the presence of actively proliferating, BrdU-labeled chon-
drocytes in the proximal region of the humerus in WT (A) and S1P
cko (B) mice. In both WT and S1P
cko mice, the initiation of hypertrophic differentiation 
caused by exit from the cell cycle is visible as a lack of BrdU incorporation (the dotted line marks the end of BrdU incorporation). (C) BrdU incorporation 
in the proximal region of the humerus in WT and S1P
cko mice, shown here as a percentage of BrdU-positive nuclei in the proliferative zone at E14.5. Error 
bars represent mean + SD. The WT value is arbitrarily assigned as 1. (D–I) In situ hybridization analyses for Ptc-1 at E14.5 (D and E), PTHrP at E13.5 
(F and G), and BSP at E13.5 (H and I) suggesting the presence of intact Ihh signaling in S1P
cko mice. Bars: (A and B) 200 μm; (D–I) 500 μm.
Figure 5.  A molecular analysis of hypertrophic differentiation in S1P
cko mice. The prehypertrophic and hypertrophic zones in S1P
cko mice are not well de-
ﬁ  ned. (A and B) The humerus of WT (A) and S1P
cko (B) mice at E14.5 was stained with Safranin O, Fast green, and hematoxylin. The proliferative to hyper-
trophic zones are shown in both cases. The chondrocytes are randomly oriented in S1P
cko mice and do not acquire the characteristic hypertrophic 
phenotype seen in the WT in spite of Runx2 (D) and Col10 (J) expression. In situ hybridization analyses in adjacent sections of the WT and S1P
cko humerus 
at E14.5 for Runx2 (C and D), Ihh (E and F), PTHrP-R (G and H), and Col10 (I and J). Bars: (A and B) 50 μm; (C–J) 500 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  692
In S1P
cko mice, however, such well-defi  ned regions are absent. 
Zones expressing Ihh (Fig. 5 F), PTHrP-R (Fig. 5 H), and Col10 
(Fig. 5 J) largely overlap each other. Thus, even though Ihh, 
Runx2, and Col10 are expressed, which indicates hypertrophic 
differentiation, the characteristic hypertrophic cell morphology 
and organization is missing in S1P
cko mice.
These results indicate that the loss of S1P does not prevent 
the molecular program necessary for hypertrophic differentiation. 
Rather, the loss of S1P appears to affect cell morphology and 
may affect matrix production. Therefore, we analyzed the ex-
pression of the matrix genes Col2 and aggrecan (Agc1) and 
MMP13 and Col10 in the E14.5 humerus (Fig. 6). At E14.5, 
chondrocyte hypertrophy is clearly established in the WT, charac-
terized by the expression of Col10 (Fig. 6 A) and the lack of 
Col2 (Fig. 6 C) and Agc1 (Fig. 6 E) expression in hypertro-
phic cells. In S1P
cko mice, however, expression of Col2 (Fig. 
6 D) and Agc1 (Fig. 6 F) is maintained into the zone of Col10-
expressing cells (Fig. 6 B). Thus, in S1P
cko mice, expression of 
hypertrophic markers is seen concomitantly with expression 
of markers for proliferating cells. However, the high levels of 
Col2 and Agc1 expression seen in the columnar cells in WT 
mice (Fig. 6, C and E, brackets) are absent in S1P
cko mice. Exit 
from the cell cycle and the expression of Runx2 and Col10 sug-
gest hypertrophic differentiation. But the lack of characteristic 
hypertrophic morphology and the persistence of Ihh, PTHrP-R, 
Col2, and Agc1 into the Col10-expressing zone suggest that 
organized transitions between various cell types are missing; 
the cells do not respond cohesively to differentiation signals 
and are therefore unable to organize themselves into structurally 
discrete zones. Finally, we checked for expression of MMP13 
at E14.5 in S1P
cko cells. MMP13 is normally expressed by the 
terminal hypertrophic cells in the growth plate (Colnot et al., 
2004). WT mice showed considerable expression of MMP13 
(Fig. 6 G) in the terminal hypertrophic chondrocytes. However, 
S1P
cko mice exhibit a dramatic decrease in MMP13 expression in 
the humerus at E14.5 (Fig. 6 H). This decrease is not a refl  ection 
of delay in differentiation but is maintained at E15.5 in S1P
cko 
mice (Fig. 6 J), which suggests a defect in terminal hypertrophic 
differentiation. However, MMP13 expression was observed in 
the perichondrium of S1P
cko mice at E15.5 presumably in the 
osteoblasts in the exuberant bone collar. These data suggest 
that S1P is required for the completion of hypertrophic differ-
entiation and organization of the hypertrophic zone.
Vascular invasion of skeletal elements 
is absent in S1P
cko mice
As demonstrated in the preceding section, hypertrophic differen-
tiation remains incomplete in S1P
cko mice. Therefore, we analyzed 
posthypertrophic differentiation events. Hypertrophic differ-
entiation is usually accompanied by the mineralization of the 
ECM, allowing for vascular invasion in a VEGF-dependent 
manner followed by the removal of hypertrophic cells by apop-
tosis (Zelzer et al., 2002). Extensive mineralization of the ECM, 
as analyzed by von Kossa staining, was observed in both the 
E15.5 tibia (Fig. 7 B) and humerus (Fig. 7 D) of S1P
cko mice, 
providing a prelude to vascular invasion. In S1P
cko mice, how-
ever, extensive abnormal mineralization of the chondrocytes 
in the humerus and to some extent in the tibia is also seen. 
Abnormal mineralization is often associated with an increase in 
apoptosis, which leads to the release of apoptotic bodies (Kirsch 
et al., 2003). Using a TUNEL assay, we studied apoptosis in 
the forelimbs of WT and S1P
cko mice at E13.75, 14.5, and 15.5. 
A considerable increase in chondrocyte apoptosis is observed in 
both the humerus (Fig. 7 F) and scapula (Fig. 7 H) in S1P
cko 
mice as compared with the WT at E15.5, but not at E13.75 
Figure 6.  Incomplete hypertrophic chondrocyte differentiation in S1P
cko 
mice. In situ hybridization analyses for Col10 (A and B), Col2 (C and D), 
Agc1 (E and F), and MMP13 (G and H) on humerus sections at E14.5 and 
for MMP13 at E15.5 (I and J). High expression of Col2 and Agc1 in the 
region of columnar chondrocytes (brackets) is absent in S1P
cko mice. Ex-
pression of Col2 and Agc1 continues into the zone of Col10-expressing 
cells in the S1P
cko humerus. Terminal hypertrophic differentiation, though 
initiated in some chondrocytes, is absent in S1P
cko mice, as seen by lack of 
MMP13 expression. Bar, 500 μm.SITE-1 PROTEASE AND CARTILAGE AND BONE • PATRA ET AL. 693
or 14.5. Next, we performed immunohistochemistry (IHC) for 
the platelet/endothelial cell adhesion molecule 1 (PECAM-1) 
antigen to analyze vascular invasion of the mineralized matrix. 
The WT humerus showed normal vascular invasion demarcat-
ing the bone from the nonvascular cartilaginous ends (Fig. 7 I). 
PECAM-1 staining is absent within the humerus in S1P
cko mice, 
suggesting a lack of vascular invasion (Fig. 7 J); however, it 
is seen in the bone collar, suggesting a defect only in endo-
chondral bone formation.
Vascular invasion takes place in a VEGF-dependent man-
ner and is needed for the invasion of osteoblastic progenitors 
and osteoclasts (Ortega et al., 2003). Osteoblasts synthesize 
MMP13 (collagenase) and osteoclasts synthesize MMP9 (gela-
tinase). The cooperative activity of these two MMPs breaks down 
the mineralized matrix of the hypertrophic cells and replaces 
it with bone matrix that is rich in Col I (Vu and Werb, 2000). 
Interestingly, both WT and S1P
cko mice demonstrated consid-
erable VEGF and MMP9 expression (Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200708092/DC1). The presence 
of MMP9-positive osteoclasts in S1P
cko mice was further confi  rmed 
by tartrate-resistant acid phosphatase–positive cells in the bone 
collar (Fig. S3). Because of the lack of endochondral bone de-
velopment in S1P
cko mice, we analyzed whether S1P
cko mice have 
a defect in osteoblast formation. Osteoblastogenesis would be 
expected to be normal in the mutants because of the proper onset 
of BSP-expressing bone collar (Fig. 4 I) and the expression of 
Runx2 (Fig. 5 D). To extend these fi  ndings, we analyzed the 
expression of Col1, the bone-specifi  c osteocalcin, and alkaline 
phosphatase, which is vital to bone morphogenesis, in S1P
cko 
mice (Fig. S3). Expression of Col1, osteocalcin, and alkaline 
phosphatase is observed in S1P
cko mice, though only in the bone 
collar because of the lack of endochondral bone. These observa-
tions indicate that S1P
cko mice have the ability to produce normal 
osteoblast progenitors and that the lack of endochondral bone 
is caused by the inability of the cartilage matrix to support osteo-
blast invasion.
Abnormal Col II properties in S1P
cko mice
Several lines of evidence suggest that matrix abnormalities are 
primarily responsible for the S1P
cko phenotype. First, chondro-
cytes are more densely packed in S1P
cko skeletal elements. Second, 
Ihh signaling is intact, as indicated by Ptc-1 and PTHrP ex-
pression, although Ptc-1 expression appears to be slightly 
disorganized. Third, it is unlikely that the reduced MMP13 ex-
pression seen in S1P
cko mice is responsible for the lack of endo-
chondral bone, as the targeted inactivation of MMP13 in mice 
does not prevent endochondral bone formation (Inada et al., 
2004; Stickens et al., 2004). Finally, the increase in chondrocyte 
apoptosis in S1P
cko mice that is suggestive of an abnormal matrix 
is also seen in transgenic mice lacking Col II (Yang et al., 1997). 
S1P may thus play a role in the deposition of a normal cartilage. 
To assess abnormalities in the matrix, we studied the properties 
of the Col II protein, which is a major cartilage component. 
First, we attempted to extract the Col II protein from E17.5 WT 
and S1P
cko cartilage by pepsin digestion after extraction of the 
proteoglycans by 4 M Gu-HCl. After pepsin digestion, the ex-
tract was concentrated and equal concentrations of protein from 
each sample were subjected to SDS-PAGE and analyzed by 
Western blotting for Col II (using the IIF antibody that detects 
the triple helical domain of Col II) and Col X protein (Fig. 8 A). 
Figure 7.  Increased chondrocyte apoptosis and absence of vascular inva-
sion in the skeletal elements of S1P
cko mice. von Kossa staining of the tibia 
(A and B) and humerus (C and D) at E15.5, suggesting normal mineraliza-
tion of the ECM in S1P
cko mice. The black arrows (B and D) depict areas of 
abnormal mineralization. Increased chondrocyte apoptosis as detected by 
a TUNEL assay is seen in the humerus (F) and scapula (H) of S1P
cko mice at 
E15.5. In E15.5 WT humorus (E) or scapula (G), hardly any apoptosis is 
observed; some apoptosis is seen at the chondroosseous junction in the hu-
merus (E, white arrows). (I) PECAM-1 IHC showing the presence of blood 
vessels in the developing bone (b) of the WT humerus and its absence in 
the cartilage (c) at E15.5. (J) PECAM-1 staining is absent in the diaphysis 
(d) of the S1P
cko humerus at E15.5 but is evident in the anomalous bone 
collar (bc). The dotted lines in panels I and J demarcate the humerus from 
the surrounding tissue and also outline the bone collar in the mutant. Bars: 
(A–D) 50 μm; (E–J) 200 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  694
We were able to extract the full-length Col II from the WT head 
(Fig. 8 A, lane 3) and the rest of its skeleton (Fig. 8 A, lane 1). 
Notably, we were not able to extract the full-length Col II from 
any of the S1P
cko skeletal elements (Fig. 8 A, lanes 2 and 4). 
In some preparations, some lower molecular weight proteins 
with immunoreactivity to the IIF antibody are seen (unpublished 
data). But we were unable to extract comparable amounts of the 
full-length Col II protein in any of our attempts. By Western 
blotting analysis of twofold dilutions of the pepsin-digested 
material, we determined that we were extracting  64-fold less 
of the full-length Col II protein from the S1P
cko mice as compared 
with WT (unpublished data). In contrast, we were able to ex-
tract comparable amounts of the Col X protein from both WT 
and S1P
cko mice.
These data suggested that the Col II protein is less abun-
dant or absent in S1P
cko mice. However, we were able to detect 
the full-length Col II procollagen in the medium of cultured 
chondrocytes from both E18.5 WT and S1P
cko mice by Western 
blotting (Fig. 8 B). Furthermore, by IHC analysis, Col II protein 
was detected in the humerus of E18.5 WT (Fig. 8 C) and S1P
cko 
(Fig. 8 D) mice. We also tested for the presence of the Col IIA 
protein (using the IIA antibody that detects exon 2), which is 
normally detected in the matrix surrounding chondroprogenitor 
cells and early immature chondrocytes. The Col IIA isoform was 
detected in both WT (Fig. 8 E) and S1P
cko mice (Fig. 8 F). In the 
WT, detection of Col IIA protein was strongest at the location of 
the early, immature chondrocytes close to the articular surface. 
Surprisingly, in S1P
cko mice, Col IIA was detected throughout 
the length of the humerus (Fig. 8 F). Therefore, we analyzed 
whether alternative splicing of the procollagen mRNA from 
Col2A to Col2B was normal in S1P
cko mice. For this analysis, we 
performed in situ hybridization using highly specifi  c 24-mer 
oligonucleotide probes spanning the exon 1 and 2 junction for 
Col2A analysis and the exon 1 and 3 junction for the Col2B anal-
ysis. Splicing of both Col2A and 2B mRNA was, however, found 
to be normal in S1P
cko mice (Fig. S4, available at http://www.jcb
.org/cgi/content/full/jcb.200708092/DC1). These data suggested 
that Col II synthesis was taking place in S1P
cko mice, although 
the turnover of Col II is abnormal, as total Col II and Col IIA was 
detected throughout the length of the humerus. These data also 
suggested that the organization of the cartilage ECM may be ab-
normal. Therefore, to assess the structural organization of the 
collagens in the ECM, we fi  rst determined the birefringent prop-
erties of the Col II fi  brils in both WT and S1P
cko mice. A marked 
Figure 8.  Abnormal Col II properties in S1P
cko mice. (A) The cartilage from the spine and limbs (1 and 2) or head (3 and 4) of WT (1 and 3) and S1P
cko 
(2 and 4) mice were pepsin digested after extraction of the proteoglycans with Gu-HCl. The pepsin-released collagens were concentrated and analyzed 
by SDS-PAGE and Western blotted for Col II (top) and Col X (bottom) proteins. (B) Western blot analysis for the Col II procollagen (Pro-Col II) from the me-
dium of WT (2) or S1P
cko (3) chondrocyte cultures (1 is control medium before the addition of chondrocytes). IHC for the Col II (C and D; IIF antibody) and 
Col IIA (E and F; IIA antibody) proteins demonstrating their expression in the mutant mice. Detection of protein was performed with DAB. Polarized light 
microscopy to analyze the birefringence properties of the Col II ﬁ  brillar network in the E16.5 humerus of WT (G) and S1P
cko (H) mice. White line in B indi-
cates that intervening lanes have been spliced out. Bar, 500 μm.SITE-1 PROTEASE AND CARTILAGE AND BONE • PATRA ET AL. 695
decrease in the birefringence of the collagen network was ob-
served in the E16.5 humerus in S1P
cko mice (Fig. 8 H) as com-
pared with the WT (Fig. 8 G), which suggests a poorly organized 
collagen fi  brillar network in the cartilage of S1P
cko mice. This re-
duced birefringence in S1P
cko mice is similar to that seen in mice 
with inactivation of the Col2a1 gene (Li et al., 1995). These data 
together suggest that one of the molecular defects caused by a 
lack of S1P is the abnormal organization of the Col II protein, 
which results in an abnormal cartilage that prevents vascular in-
vasion and endochondral ossifi  cation in S1P
cko mice.
To pursue this observation further, we performed double-
labeled immunofl  uorescence analysis with the IIA and IIF 
antibodies (Zhu et al., 1999) to study the organization and localiza-
tion of the Col II protein (Fig. 9). In the WT, the secretion and 
incorporation of Col IIA into the matrix is seen as a well-formed 
and organized green lattice network. Localization of the colla-
gen triple helical domains is seen as red immunofl  uorescence, 
which in the WT is seen as a distinct red lattice network with 
hardly any yellow colocalization signals from the two anti-
bodies, suggesting that the red lattice is almost entirely made of 
Col IIB protein. As expected in the WT, the presence of Col IIA 
is stronger in the matrix surrounding the early immature chon-
drocytes (Fig. 9 B) and the presence of Col IIB is stronger 
around the more mature columnar chondrocytes (Fig. 9 C). In 
S1P
cko mice (Fig. 9, F and G), the organization of the Col IIA 
lattice network appears normal, though it is also prominent in 
the matrix surrounding mature chondrocytes (Fig. 9 G). How-
ever, in the matrix surrounding early chondrocytes (Fig. 9 F), 
well-formed organization of Col IIB fi  brils (red) is consider-
ably reduced and the majority of the signal appears to be caused 
by colocalization (yellow), suggesting that both antibodies are 
detecting primarily Col IIA and very little Col IIB. In the ma-
trix surrounding more mature chondrocytes (Fig. 9 G), the lat-
tice network is primarily green with very little incorporation of 
Col IIB (red signaling) into the lattice network of the ECM. 
Most of the Col IIB protein (Fig. 9 G, arrows) is seen trapped 
inside the cell. The lack of matrix accumulation can be seen 
more clearly in cross sections of the ribs (at E18.5) in S1P
cko 
Figure 9. Abnormal  collagen  ﬁ  bril deposition and ER stress in S1P
cko mice. Double-labeled immunoﬂ  uorescence studies with the IIA and IIF antibodies in 
the E15.5 humerus (A–C and E–G) and E18.5 rib cross sections (D and H) in WT (A–D) and S1P
cko (E–H) mice showing abnormal collagen ﬁ  bril deposition 
and entrapment of Col IIB protein (G, arrows) within the cell in the mutant mice. B and F are higher magniﬁ  cation images of the regions outlined by the 
black boxes in A and E, and C and G are higher magniﬁ  cation images of the regions outlined by the white boxes. In the WT, colocalization of IIA and IIF 
antibodies is seen only at the rim of the rib (D, arrow). Colors represent antibody localizations as follows: green, Col II exon 2 (IIA); red, Col II triple helical 
domain (IIF); yellow, colocalization of both antibodies. Electron microscopy images of the cartilage matrix and chondrocytes of the proliferative zone in 
E15.5 WT (I–K) and S1P
cko (L–N) tibia. J and M emphasize the cartilage ECM, showing the decrease in collagen ﬁ  brillar density in the S1P
cko matrix, and 
K and N emphasize the intracellular organization, particularly the engorged and fragmented ER in the mutant mice (black arrows). The engorged ER in the 
mutant is ﬁ  lled with materials that appear homogenously or heterogeneously stained with partially crystalline appearance (N, white arrow). Bars: (A and E) 
500 μm; (B–D and F–H) 84 μm; (I and L) 2 μm; (J and M) 2 μm; (K and N) 1 μm.JCB • VOLUME 179 • NUMBER 4 • 2007  696
mice (Fig. 9 H). Again, primarily colocalization signals (yellow) 
and the substantial absence of matrix when compared with the 
WT (Fig. 9 D) is observed, which showed abundant matrix (red) 
with yellow colocalization signals restricted to the rim of the rib.
These data suggested that in S1P
cko mice, although there is 
no problem in the expression and secretion of Col IIA and its 
incorporation into the matrix, the expression and/or secretion of 
Col IIB is abnormal and results in a matrix with considerably re-
duced levels of Col IIB and therefore an inability to extract Col II 
from the matrix (Fig. 8 A). To understand the mechanism for this 
defect, we performed electron microscopic analysis of tibia 
(Fig. 9, I–N) and humerus (not depicted) from E15.5 WT and 
S1P
cko mice. In the WT (Fig. 9, I–K), the cartilage from the pro-
liferative zone showed the presence of well-formed and abun-
dant, homogenous Col II fi  brils surrounding normal chondrocytes. 
In S1P
cko mice, however (Fig. 9, L–N), the distribution of colla-
gen fi  bril density is irregular and considerably reduced. The ER 
is drastically enlarged, irregular in shape, and fragmented and 
also often found fi  lled with granular, homogenous, or hetero-
genously stained material that also sometimes appears to be crys-
talline. Similar observations were seen in the chondrocytes/ECM 
of the articular, hypertrophic, and joint cartilage regions in S1P
cko 
mice. These data suggest the induction of ER stress in chondro-
cytes in S1P
cko mice, presumably caused by the excessive de-
mand for complex matrix protein synthesis required for cartilage 
deposition, and a requirement for S1P activity to alleviate ER 
stress during matrix protein synthesis and deposition.
Discussion
In this paper, we have established the importance of S1P to car-
tilage deposition and endochondral ossifi  cation. Null mice with 
a loss of S1P in all tissues were found to be embryonic lethal at 
a very early stage and therefore did not provide a suitable ave-
nue to study its contribution to cartilage and bone development 
(Yang et al., 2001). Our studies on S1P
cko mice have   allowed us to 
focus on the requirement of S1P in chondrocyte differentiation 
and the genesis of a normal endochondral skeleton. Cartilage-
specifi  c disruption of S1P in S1P
cko mice results in total lack of 
endochondral bone in all skeletal elements that exhibit longitu-
dinal bone growth through endochondral ossifi  cation.
The lack of endochondral bone seen in S1P
cko mice is also 
seen in Ihh (St-Jacques et al., 1999) and Runx2 null mice (Komori 
et al., 1997; Otto et al., 1997). In both these mutants, endochon-
dral bone development is hampered because of a defect in 
osteoblastogenesis. Both Ihh and Runx2 null mice also suffer 
from varying degrees of an abnormal chondrocyte differentia-
tion program (Inada et al., 1999; Kim et al., 1999). In S1P
cko 
mice, we initially expected that the phenotype could have arisen 
because of a defect in the Ihh signaling pathway. However, our 
data suggest that S1P
cko mice have an intact Ihh signaling path-
way, as indicated by the expression of Ptc-1 and PTHrP in 
S1P
cko skeletal elements. However, the mislocalization of Ptc-1–
expressing cells leaves open the possibility that S1P has an ef-
fect on the activity level and/or diffusion of Ihh. The morphological 
phenotype that sets S1P
cko mice apart from Ihh and Runx2 null 
mice is that S1P
cko mice exhibit an exuberant bone collar show-
ing normal osteoblastogenesis. Elimination of S1P results in an 
uncoupling of normal endochondral bone formation from corti-
cal bone formation. Thus, like Ihh and Runx2, S1P is a major 
positive regulator of endochondral ossifi  cation. Expression of 
S1P is observed in the perichondrium in the WT. However, in 
S1P
cko mice, S1P activity would be expected to be absent in the 
perichondrium because of active Col2-Cre activity in these 
cells. These data suggest that S1P is not necessary for cortical 
bone formation. Mice with double knockouts of the transcrip-
tion factors L-Sox5 and Sox6 also exhibit a lack of endochon-
dral ossifi  cation with development of a thick cortical bone (Smits 
et al., 2001). However, it is unlikely that this pathway is affected 
in S1P
cko mice, as they exhibit abundant expression of L-Sox5 
and Sox6 (unpublished data).
The lack of endochondral bone in S1P
cko mice appears to 
be caused by an inability of the blood vessels to invade the 
abnormal, mineralized cartilage in spite of apparently adequate 
VEGF expression. According to the tenets of organogenesis, 
where development is guided by tissue interactions, the devel-
opmental history of a tissue plays an important role in its ability 
to respond to instructive cues (De Robertis, 2006). Thus, it 
would be expected that an abnormal cartilage would constrain 
its ability to respond to instructions from the perichondrium 
and/or vascular tissue. The genesis of a normal matrix is neces-
sary for proper hypertrophic differentiation and endochondral 
ossifi  cation. Our data suggest that the defects in hypertrophic 
differentiation and endochondral ossifi  cation can be traced to an 
abnormal matrix in S1P
cko mutants. In S1P
cko mice, the chondro-
cytes are densely packed and randomly oriented with very little 
matrix between them. The increased chondrocyte apoptosis 
seen in S1P
cko mice is also highly indicative of an abnormal car-
tilage that is unable to support chondrocyte survival. This is 
similar to the increased apoptosis seen in transgenic mice lack-
ing Col II (Yang et al., 1997). The absence of a proper cartilage 
could hinder not only the supply of nutrients to the avascular 
ECM (Hunziker and Herrmann, 1990) but also have profound 
effects on integrin-mediated pathways and distribution of 
growth factors (Yoon and Fisher,  2006). The inability to extract 
normal amounts of full-length Col II from cartilage, the de-
creased birefringence of Col II network, the lack of the Col IIB 
lattice network, and the considerable reduction in collagen 
fi  brillar density as seen by electron microscopy all attest to the 
fact that the cartilage is abnormal in S1P
cko mice. S1P
cko mice 
also exhibit abnormal spine development in that the interverte-
bral discs are not well formed and lack the gelatinous nucleus 
pulposus in the center. This is also seen in transgenic mice with 
a null mutation in the Col2a1 gene (Aszodi et al., 1998).
An abnormal cartilage ECM could mask angiogenic sig-
naling by VEGF in spite of the adequate VEGF expression that 
is seen in S1P
cko mice. Given the abnormal characteristics of the 
cartilage matrix, even if VEGF is not masked, the MMPs may not 
be able to process and break down the alien matrix in S1P
cko 
mice. An inability to degrade the matrix is suggested by the per-
sistence of Col IIA in the S1P
cko cartilage, as Col IIA is seen 
throughout the length of the humerus. These observations are 
highly suggestive of a lack of structurally intact cartilage matrix 
in S1P
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bone development. Some of the phenotypes seen in S1P
cko mice 
also bear resemblance to the phenotypes seen in mutants for other 
matrix proteins. For example, a lack of columnar hypertrophic 
chondrocytes, disorganized growth plates, chondrodysplasia, and 
incomplete nucleus pulposus are seen in mice lacking perlecan 
(Arikawa-Hirasawa et al., 1999; Gustafsson et al., 2003), 
Agc1 (Watanabe et al., 1994; Wai et al., 1998), and/or link protein 
(Watanabe and Yamada, 1999). These observations clearly attest 
to the importance of a properly organized matrix for chondrocyte 
differentiation. However, these mutations exhibit only reduced 
or delayed endochondral ossifi  cation. Thus, it is noteworthy 
that only the disruption of the Col2a1 gene (Li et al., 1995) results 
in a complete lack of endochondral ossifi  cation as seen in S1P
cko 
mice. These data suggest a convergence of S1P activity with a 
property of Col II in relation to the cartilage matrix.
Thus, our paper shows that S1P is essential to endochon-
dral ossifi  cation. The much accepted role of S1P is that of a 
proprotein convertase required to activate the transcription fac-
tors SREBPs, ATF6, OASIS, and CREBH, the latter three play-
ing vital roles during ER stress response. Given that the knockout 
of the SREBP molecules has not exhibited any known defect in 
bone morphogenesis in mice that escape embryonic lethality 
(Shimano et al., 1997; Liang et al., 2002), it seems unlikely that 
the phenotype in S1P
cko mice is manifested through SREBPs. 
Furthermore, in the zebrafi  sh gonzo phenotype, knockdown of 
SCAP (the lipid sensor) results only in strong lipid phenotypes 
with normal cartilage (Schlombs et al., 2003). These data sug-
gest that the abnormal cartilage phenotype in S1P
cko mice is me-
diated by lipid-independent pathways. Given the engorgement 
and fragmentation of the ER in S1P
cko mice, it seems likely that 
S1P is required to activate ER stress signaling (ERSS) in re-
sponse to the hyperproduction of complex cartilage matrix pro-
teins seen in chondrocytes. Unlike other studies (Tsang et al., 2007), 
it is noteworthy that the ER stress observed in S1P
cko mice 
is not caused by the introduction of any mutant matrix pro-
tein but by the inability of the chondrocyte to respond to ER 
stress because of a lack of S1P activity. Based on these data we 
propose that the ER stress response is part of the vital protein 
processing machinery in normal chondrocytes and is essential 
for normal matrix production (Fig. 10). In a normal chondro-
cyte differentiation program, chondroprogenitor cells do not re-
quire ER stress response because of the relatively low level of 
protein synthesis and secrete Col IIA into the matrix. However, 
on differentiation into chondrocytes, to alleviate the stress 
caused by the high demand for complex matrix protein synthe-
sis, the chondrocytes initiate ERSS, a mechanism that requires 
S1P to activate ATF6, OASIS, or CREBH (currently the three 
known ER stress signal transducers that require activation by 
S1P). This allows for the deposition of normal cartilage fol-
lowed by endochondral ossifi  cation. In S1P
cko mice, chondro-
progenitor cells do not show any defect in the secretion of Col IIA 
either because of the level of Col IIA synthesis or the different 
dynamics of Col IIA secretion. However, upon differentiation 
into chondrocytes and a switch to the alternatively spliced form 
Col IIB and the concomitant increase in protein synthesis and 
secretion, S1P
cko mice are unable to initiate the ER stress response 
because of an inability to activate the appropriate transcription 
factors in the absence of S1P. This results in the engorgement and 
fragmentation of the ER followed by poor Col IIB secretion into 
the matrix, which results in the matrix acquiring the properties 
typically seen on disruption of the Col2a1 gene. Other cell types, 
such as the periosteal cells, which lack S1P but do not require the 
same ER stress response, are able to synthesize bone, as seen 
in S1P
cko mice. Thus, chondrocytes in this respect are like the dif-
ferentiating plasma cells, which turn on the unfolded protein re-
sponse to alleviate ER stress and optimize antibody secretion 
Figure 10.  A model for the requirement of 
S1P in the ER stress response for the genesis 
of a normal cartilage matrix. TF, transcrip-
tion factor.JCB • VOLUME 179 • NUMBER 4 • 2007  698
(Gunn et al., 2004), or exocrine glands, where the ER stress 
response is necessary for the full development of the secretory 
machinery (Lee et al., 2005).
In the zebrafi  sh S1P gonzo mutants, ER stress and un-
folded protein response were reported to be normal based on in 
situ hybridization to two mRNA sequences known to be down-
stream of ATF6. In light of recent discoveries, this assessment 
may have been misleading. First, the analysis in gonzo mutants 
involved the in situ analysis of the full-length XBP1 mRNA and 
not the specifi  c splice form necessary for ER stress response 
(Yoshida et al., 2001; Calfon et al., 2002). Second, the presence 
of immunoglobulin heavy chain binding pretien (BiP) chaper-
one does not ensure an adequate ERSS in chondrocytes, and BiP 
can be regulated by other transcription factors such as NF-Y 
(Yoshida et al., 2000). In preliminary experiments, we also de-
tect BiP expression in both WT and S1P
cko mice (unpublished 
data). Lastly, besides ATF6, at least two other ERSS transcrip-
tion factors, OASIS and CREBH, are regulated by S1P. Collec-
tively, these observations suggest the requirement of a new 
specialized pathway for regulation of matrix protein synthesis 
in chondrocytes. We are currently investigating these possibil-
ities using our mouse model to provide a more complete picture 
of the utility of S1P in ER stress response, matrix synthesis, and 
endochondral bone formation.
Materials and methods
Generation of S1P
cko mice
To generate S1P
cko mice, S1P
f/f mice (mice homozygous for the S1P
ﬂ  ox al-
lele in which the exon 2 of S1P is ﬂ  oxed, provided by J.D. Horton, Univer-
sity of Texas Southwestern Medical Center, Dallas, TX; Yang et al., 2001) 
were bred with Col2-Cre (where the Cre recombinase is under the inﬂ  u-
ence of the cartilage-speciﬁ  c Col2a1 promoter, limiting its expression pri-
marily to cartilage; a gift of D. Ornitz, Washington University School of 
Medicine, St. Louis, MO; Jacob et al., 2006) transgenic mice of the 
C57BL/6J strain to produce S1P
f/+;Col2-Cre mice (mice heterozygous for 
the S1P
ﬂ  ox allele and positive for the Col2-Cre transgene). The S1P
f/+;Col2-
Cre mice were bred with S1P
f/f mice to generate S1P
cko mice. Genotypes 
were veriﬁ  ed by PCR analysis of tail-derived DNA.
Isolation of collagens from WT and S1P
cko mice
The isolation of collagens was done from E17.5 WT and S1P
cko mice using 
a modiﬁ  cation of previously published protocols (Mayne et al., 1995). 
In brief, E17.5 embryos were skinned and eviscerated, and the head was 
processed separately from the rest of the body. The spine/limbs and head 
were frozen and crushed, and the proteoglycans were extracted with 4 M 
Gu-HCl in 0.05 M Tris-HCl, pH 7.5, containing 0.01 M EDTA and a 1× 
complete protease inhibitor cocktail (Roche), for 36 h at 4°C. The cartilage 
residues left after proteoglycan extraction were washed with cold water 
and digested with 1 mg/ml pepsin in 0.5 M acetic acid for 24 h at 4°C. 
The digest was then concentrated with centricon30 (Millipore) to  250 μl, 
dialyzed against 0.05 M Tris-HCl, pH 7.5, buffer containing 0.4 M NaCl 
and 5 mM EDTA, and stored at −20°C. Equal concentrations of protein 
preparations (determined by Bio-Rad Laboratories protein assay) from WT 
and S1P
cko mice were separated by SDS-PAGE followed by Western blot-
ting for Col II (using the previously described rat antibody IIF against 
bovine Col II triple helical domain; Zhu et al., 1999) and Col X proteins 
(EMD). The molecular weight marker used in SDS-PAGE was BenchMark 
prestained protein ladder (Invitrogen).
Primary chondrocyte cultures from WT and S1P
cko mice
To study the biosynthesis and secretion of the Col II protein in vitro, primary 
cultures from WT and S1P
cko mice were established. Chondrocytes were 
isolated from the sternum and ribs of WT and S1P
cko mice as described 
previously (Lefebvre et al., 1994). In brief, rib cages were taken from WT 
or S1P
cko mice and treated with 2 mg/ml pronase (Roche) at 37°C for 
30 min followed by 3 mg/ml collagenase (Roche) treatment in the pres-
ence of 8% CO2 for 1.5 h at 37°C or until all soft tissues are detached from 
the cartilage. The cartilage was then separated from the soft tissues and 
treated again with 3 mg/ml collagenase for 4 h at 37°C in the presence of 
5% CO2. The digest was ﬁ  ltered through a cell strainer to remove un-
digested bony parts and the cells were then pelleted by centrifugation, 
washed with 1× PBS, and plated at a density of 2.5 × 10
5 per cm
2 in 
DME with 10% heat-inactivated serum, 2% penicillin/streptomycin (Sigma-
Aldrich), and 0.25 mM sodium ascorbate. 50 μl of media from the WT 
and S1P
cko chondrocyte cultures was harvested at regular intervals and 
separated by 7.5% SDS-PAGE (Bio-Rad Laboratories), and the type II pro-
collagen was detected by Western blotting using the IIF antibody.
Morphological and histological analysis
Whole-mount skeletal staining of embryos by alcian blue and alizarin red 
was performed as described previously (McLeod, 1980). For histological 
and in situ hybridization analyses on sections, embryonic tissues were col-
lected at various embryonic time points and processed and sectioned as 
described previously (Hilton et al., 2005). Histological analyses were done 
primarily by Safranin O, Fast green, and hematoxylin staining. Detection 
of mineralization was performed by staining with 1% silver nitrate as per 
the von Kossa method, followed by counterstaining with Methyl green. 
In situ hybridization analyses were performed using 
35S-labeled riboprobes 
as described previously (Long et al., 2001). All in situ probes with the ex-
ception of Agc1 were provided by F. Long (Washington University School 
of Medicine) and have been described by Hilton et al. (2005) and refer-
ences therein. The Agc1 in situ probe (a gift of E. Vuorio, University of 
Turku, Turku, Finland) covering the IGD sequence of the mouse Agc1 has 
been described previously (Glumoff et al., 1994). The full-length S1P and 
the S1P exon 2 in situ probes were derived from a full-length cDNA clone 
(American Type Culture Collection). For BrdU analyses, pregnant females 
were injected with BrdU as described previously (Hilton et al., 2005), and 
proliferation of chondrocytes was analyzed using a kit (Invitrogen). For 
PECAM-1 IHC, embryos were ﬁ  xed using 4% formaldehyde followed by 
30% sucrose inﬁ  ltration. 10-μm cryostat sections were derived from tissues 
embedded in OCT (Tissue-Tek; Thermo Fisher Scientiﬁ  c) and IHC was per-
formed using a monoclonal rat anti–mouse PECAM-1 antibody (BD Bio-
sciences). Detection of PECAM-1 was done using HRP-conjugated anti–rat 
IgG and DAB. Methyl green was used for counterstaining. Detection of 
apoptosis was performed by a TUNEL assay using the in situ cell death de-
tection kit (Roche) according to the manufacturer’s instructions. Nuclei were 
counterstained with DAPI and sections were examined by ﬂ  uorescence 
microscopy. Tartrate-resistant acid phosphatase–positive cells were stained 
using standard procedures with methyl green as counterstain. Study of the 
birefringence of collagen ﬁ  bers by polarized light microscopy was done 
on 5-μm-thick parafﬁ  n-embedded sections as described previously (Li et al., 
1995). Detection of total Col II protein by IHC was done on 5-μm-thick 
parafﬁ  n-embedded sections at E15.5 and 18.5 stages using the IIF anti-
body and procedure described previously (Zhu et al., 1999), with the ex-
ception that detection was done using an HRP-conjugated goat anti–rat 
secondary antibody and a DAB substrate (Invitrogen). Detection of Col IIA 
protein was done similarly with the previously described rabbit antisera 
against recombinant human type IIA-GST (IIA; Oganesian et al., 1997; 
Zhu et al., 1999) and an HRP-conjugated goat anti–rabbit secondary anti-
body. Double-labeled immunoﬂ  uorescence with IIF and IIA antibodies was 
performed as described previously (Zhu et al., 1999) on parafﬁ  n embed-
ded sections, with the exception that the IIA and IIF antibodies (and their 
corresponding secondary antibodies) were used sequentially with the IIA 
antibody and its secondary antibody applied ﬁ  rst. The secondary antibod-
ies used were goat anti–rabbit Alexa Flour 488 (Invitrogen) and goat anti–
rat Alexa Fluor 546 (Invitrogen). Images for double immunoﬂ  uorescence 
were collected with a 60×, 1.4 NA oil immersion objective using either a 
scanning laser confocal microscope (for E18.5 ribs cross sections; 
MRC600; Bio-Rad Laboratories) mounted on a microscope (Eclipse E800; 
Nikon) and LaserSharp 2000 software (Bio-Rad Laboratories) or a camera 
(2000R Fast1394; Retiga)and Q Capture Pro (for limbs; QImaging). All 
other sections (in situ/histology) were viewed with a microscope (BX51; 
Olympus) using a 10× objective (all in situ analysis) or 20 and 40× objec-
tives (for stained sections or IHC), and images were captured with the digi-
tal camera (DP70; Olympus) using DP controller software (Olympus). For in 
situ analysis, pictures of hybridization signals were hued red and super-
imposed on toluidine blue–counterstained images using Photoshop (Adobe).
Online supplemental material
Fig. S1 shows the lack of endochondral ossiﬁ  cation in the femur, ribs, ster-
num, and spine of S1P
cko mice. Fig. S2 shows the abnormal hypertrophic SITE-1 PROTEASE AND CARTILAGE AND BONE • PATRA ET AL. 699
differentiation in S1P
cko mice. Fig. S3 shows normal VEGF and MMP9 expres-
sion and normal osteoblastogenesis in S1P
cko mice. Fig. S4 shows normal 
Col2 mRNA splicing in S1P
cko mice. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200708092/DC1.
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